Diosgenin derivative ML5 attenuates MPTP-induced neuronal impairment via regulating AMPK/PGC-1α-mediated mitochondrial biogenesis and fusion/fission.
Jing-Jing FanWei-Dong DingYing-Fan LiangYao-Xin WeiYi HuangLei MaRui Wang
Published in: American journal of translational research (2024)
-induced mitochondrial dysfunction and neuronal injury via promoting AMPK/PGC-1α signaling activation and be used as a therapeutic drug for PD treatment.